Extended Survival in a Dog with Primary Bone Hemangiosarcoma Following Treatment with Neoadjuvant Oncolytic Virotherapy and Standard of Care

A three year old male neutered mixed breed dog presented with a mass on the right carpus and accompanying lameness. A Jamshidi bone biopsy was performed, and histopathology results were consistent with a sarcoma. The dog received oncolytic virotherapy (OV) with vesicular stomatitis virus (VSV) as pa...

Full description

Bibliographic Details

Published in:	Veterinary Sciences
Main Authors:	Courtney Labé, Andrea Chehadeh, Amber Winter, Sara Pracht, Kathy M. Stuebner, Mitzi Lewellen, Bishoy Eskander, M. Gerard O’Sullivan, Alexandru-Flaviu Tabaran, Christopher Ober, Michael S. Henson, Davis Seelig, Steve J. Russell, Jaime F. Modiano, Shruthi Naik, Kelly M. Makielski
Format:	Article
Language:	English
Published:	MDPI AG 2025-09-01
Subjects:	cancer dog canine hemangiosarcoma virotherapy doxorubicin
Online Access:	https://www.mdpi.com/2306-7381/12/10/921